1. Montanaro A, Bennett RM. Myelopathy in Reiter's disease. J Rheumatol. 1984. 11:540–541.
2. Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol. 2005. 17:400–405.
Article
3. Hermann E, Yu DT, Meyer zum Buschenfelde KH, Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993. 342:646–650.
Article
4. Colmegna I, Espinoza LR. Recent advances in reactive arthritis. Curr Rheumatol Rep. 2005. 7:201–207.
Article
5. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002. 136:896–907.
Article
6. Unverferth DV, Beman FM, Ryan JM, Whisler RL. Reiter's aortitis with pericardial fluid, heart block and neurologic manifestations. J Rheumatol. 1979. 6:232–236.
7. Cuchacovich M, Gatica H, Contreras L. Neurologic involvement in Reiter's disease. Report of 2 cases. Rev Med Chil. 1991. 119:687–690.
8. Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Groh A, Uksila J, et al. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis. 2001. 60:337–343.
Article
9. Palazzi C, Olivieri I, D'Amico E, Pennese E, Petricca A. Management of reactive arthritis. Expert Opin Pharmacother. 2004. 5:61–70.
Article